Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease

Background Fatty liver is a major cause of obesity-related morbidity and mortality. The aim of this study was to identify early metabolic alterations associated with liver fat accumulation in 50- to 55-year-old men (n = 49) and women (n = 52) with and without NAFLD. Methods Hepatic fat content was measured using proton magnetic resonance spectroscopy (1H MRS). Serum samples were analyzed using a nuclear magnetic resonance (NMR) metabolomics platform. Global gene expression profiles of adipose tissues and skeletal muscle were analyzed using Affymetrix microarrays and quantitative PCR. Muscle protein expression was analyzed by Western blot. Results Increased branched-chain amino acid (BCAA), aromatic amino acid (AAA) and orosomucoid were associated with liver fat accumulation already in its early stage, independent of sex, obesity or insulin resistance (p<0.05 for all). Significant down-regulation of BCAA catabolism and fatty acid and energy metabolism was observed in the adipose tissue of the NAFLD group (p<0.001for all), whereas no aberrant gene expression in the skeletal muscle was found. Reduced BCAA catabolic activity was inversely associated with serum BCAA and liver fat content (p<0.05 for all). Conclusions Liver fat accumulation, already in its early stage, is associated with increased serum branched-chain and aromatic amino acids. The observed associations of decreased BCAA catabolism activity, mitochondrial energy metabolism and serum BCAA concentration with liver fat content suggest that adipose tissue dysfunction may have a key role in the systemic nature of NAFLD pathogenesis.

[1]  Lynne Pearce,et al.  Non-alcoholic fatty liver disease. , 2016, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  K. Cusi,et al.  Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. , 2015, American journal of physiology. Endocrinology and metabolism.

[3]  Y. Takei,et al.  Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. , 2015, Obesity research & clinical practice.

[4]  P. Flachs,et al.  Lipid signaling in adipose tissue: Connecting inflammation & metabolism. , 2015, Biochimica et biophysica acta.

[5]  D. Bernlohr,et al.  Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes. , 2015, Molecular endocrinology.

[6]  N. Araníbar,et al.  Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease , 2014, Amino Acids.

[7]  Shasha Zhang,et al.  CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. , 2014, American journal of physiology. Endocrinology and metabolism.

[8]  H. Yki-Järvinen.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.

[9]  Eun Soo Kim,et al.  Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees , 2014, PloS one.

[10]  R. Nagarajan,et al.  A pilot validation of multi‐echo based echo‐planar correlated spectroscopic imaging in human calf muscles , 2014, NMR in biomedicine.

[11]  C. Alonso,et al.  Deciphering non-alcoholic fatty liver disease through metabolomics. , 2014, Biochemical Society transactions.

[12]  S. Tuomela,et al.  Gut-adipose tissue axis in hepatic fat accumulation in humans. , 2014, Journal of hepatology.

[13]  J. Menéndez,et al.  Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease , 2014, International Journal of Obesity.

[14]  U. Kujala,et al.  Serum metabolic profiles in overweight and obese women with and without metabolic syndrome , 2014, Diabetology & Metabolic Syndrome.

[15]  Jun Zou,et al.  Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men – the role of gut microbiota composition: study protocol for the AELC randomized controlled trial , 2014, BMC Public Health.

[16]  E. Moser,et al.  Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans , 2014, Diabetes Care.

[17]  M. Orešič,et al.  Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity , 2013, Diabetes.

[18]  J. Idle,et al.  The metabolomic window into hepatobiliary disease. , 2013, Journal of hepatology.

[19]  A. Zell,et al.  Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver , 2013, Diabetes Care.

[20]  Bryan C. Batch,et al.  Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. , 2013, Metabolism: clinical and experimental.

[21]  J. Deanfield,et al.  The Year in Cardiology 2012: focus on cardiovascular disease prevention. , 2013, European heart journal.

[22]  K. Petersen,et al.  Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly , 2012, Diabetes.

[23]  T. Törmäkangas,et al.  Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. , 2012, The Journal of clinical endocrinology and metabolism.

[24]  Y. Shibata,et al.  Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model , 2012, International journal of cancer.

[25]  Tuija Tammelin,et al.  Metabolic Signatures of Insulin Resistance in 7,098 Young Adults , 2012, Diabetes.

[26]  N. Stefan,et al.  The Metabolically Benign and Malignant Fatty Liver , 2011, Diabetes.

[27]  M. Alen,et al.  Is bone loss the reversal of bone accrual? evidence from a cross‐sectional study in daughter‐mother‐grandmother trios , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  M. Milburn,et al.  Plasma metabolomic profile in nonalcoholic fatty liver disease. , 2011, Metabolism: clinical and experimental.

[29]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[30]  T. Roskams,et al.  Adipose Tissue Dysfunction Signals Progression of Hepatic Steatosis Towards Nonalcoholic Steatohepatitis in C57Bl/6 Mice , 2010, Diabetes.

[31]  A. Gastaldelli,et al.  Insulin resistance, adipose depots and gut: interactions and pathological implications. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[32]  B. Kahn,et al.  Adipose Tissue Branched Chain Amino Acid (BCAA) Metabolism Modulates Circulating BCAA Levels* , 2010, The Journal of Biological Chemistry.

[33]  F. Tylavsky,et al.  Long‐term leisure‐time physical activity has a positive effect on bone mass gain in girls , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[35]  Reino Laatikainen,et al.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.

[36]  William E. Kraus,et al.  Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women , 2009, Diabetes Care.

[37]  E. Tsochatzis,et al.  Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy , 2009, Mediators of inflammation.

[38]  G. Goossens.  The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance , 2008, Physiology & Behavior.

[39]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[40]  Leena Peltonen,et al.  Global Transcript Profiles of Fat in Monozygotic Twins Discordant for BMI: Pathways behind Acquired Obesity , 2008, PLoS medicine.

[41]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[42]  F. Tylavsky,et al.  Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. , 2005, The American journal of clinical nutrition.

[43]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[44]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[45]  V. Almendro,et al.  Cross‐talk between skeletal muscle and adipose tissue: A link with obesity? , 2005, Medicinal research reviews.

[46]  E. Ravussin,et al.  Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus , 2004, International Journal of Obesity.

[47]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[48]  S. Provencher.  Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[49]  P. Trayhurn.  Hypoxia and adipose tissue function and dysfunction in obesity. , 2013, Physiological reviews.

[50]  Riitta Parkkola,et al.  Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. , 2009, Radiology.

[51]  X. Papademetris,et al.  Inaugural Article: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007 .

[52]  M. Brosnan,et al.  Branched-chain amino acids: enzyme and substrate regulation. , 2006, The Journal of nutrition.

[53]  Kristopher J Preacher,et al.  On the practice of dichotomization of quantitative variables. , 2002, Psychological methods.

[54]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[55]  F. Tylavsky,et al.  Bmc Medicine Trait-specific Tracking and Determinants of Body Composition: a 7-year Follow-up Study of Pubertal Growth in Girls , 2022 .